Mederma

Quick links to important sections

Mederma

Method of action: Diuretic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mederma

Quick Facts

Property Description
Active ingredient Cepalin (Allium Cepa Extract), Dimethicone, Allantoin (Varies by form)
Form Gel, Cream, or Oil
Pharmacological class Topical Emollient, Skin Protectant
Common use Aesthetic improvement of scar appearance
Origin Derived (Botanical extract combined with synthetic/natural substances)

Pharmacological Classification and Identity

Mederma is a prominent over-the-counter (OTC) topical product for scar management, categorized as both a Topical Emollient and a Skin Protectant in its most widely available dosage forms, including the characteristic Gel and Cream. Its identity as a combination product is distinct, as it merges a unique botanical component with established skin-protecting agents. The use of key ingredients like Dimethicone is backed by regulatory recognition for skin protection.

The Core Composition and Differentiation

The brand is differentiated by the inclusion of Cepalin, a proprietary botanical extract sourced from the Allium Cepa (Onion) Bulb. This extract is integrated with pharmaceutical active ingredients such as Allantoin or the barrier agent Dimethicone. Research suggests that the constituents of Allium Cepa possess biologically relevant properties, including antioxidant and anti-inflammatory activities. The product is typically formulated with an Aqueous/Water-based vehicle, making it suitable for direct cutaneous application.

General Purpose: Supporting Scar Appearance

The general purpose of Mederma is to visibly enhance the aesthetic quality of scars resulting from various sources, such as post-surgical incisions or healed injuries. Its Triple Action Formula is clinically recognized for its ability to promote deep and sustained hydration of the scar tissue. A review of scar treatments further emphasized the efficacy of barrier compounds like Dimethicone in preventing water loss, which is essential for maintaining scar pliability and healing. By modulating moisture and supporting optimal collagen formation, the product’s intended benefit is to help the scar become noticeably softer, smoother, and better blended with the surrounding skin.

Regulatory References

  1. FDA Human OTC Drug Monograph system
  2. NIH Research Review

What side effects are possible with Mederma?

Possible side effects and safety information

The safety profile for Mederma, a topical product for scar management, is focused on localized skin reactions at the application site, consistent with its classification as a topical emollient and skin protectant. The frequency of most adverse events is typically not known, as official labeling for over-the-counter products often relies on post-market surveillance rather than establishing precise commonality tiers.


Officially Documented Adverse Reactions

Adverse effects listed in regulatory documents pertain almost entirely to the Skin and Subcutaneous Tissue Disorders system. These common and expected adverse reactions include localized responses at the site of application, such as irritation, redness (erythema), stinging, swelling, and itching (pruritus).

Safety Restrictions and Serious Events

Regulatory safety information highlights the risk of more significant local reactions, specifically allergic contact dermatitis or a severe hypersensitivity reaction to one of the product's components. Any excessive, worsening, or persistent irritation or rash is classified as an event requiring the discontinuation of use.

The most important constraint governing the safe use of the product is related to skin integrity: Mederma is strictly intended for use only on intact, healed skin. The product is not to be applied to open wounds or broken skin, a fundamental restriction defined in official regulatory labeling.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory information for Mederma, an over-the-counter (OTC) topical product, addresses overdose by focusing on mandatory emergency actions following accidental ingestion. No specific systemic clinical manifestations, symptoms, or signs of overdose related to topical overuse are explicitly documented in official regulatory labeling.

Overdose Scope

The circumstance requiring urgent action is strictly accidental ingestion (swallowing) of the product. Immediate medical help is required, and contacting a Poison Control Center right away is the specific action mandated by the official warnings. The regulatory text does not specify physiological systems affected or document any population-specific overdose considerations.

Overdose Classifications

The regulatory basis for the mandated emergency actions is derived from the FDA / DailyMed OTC Drug Facts label. The official documentation does not define a formal severity classification for overdose or specify procedures for supportive management, instead deferring all intervention details to medical professionals upon contact. The overdose-context constraints are strictly limited to the scenario of accidental swallowing.

Official Overdose Statements

The official guidance strictly mandates that immediate medical help must be sought if the product is swallowed. No other specific overdose statements regarding complications or specific supportive care are documented in the regulatory text.

Therapeutic Uses of Mederma

What Mederma Treats: Main Uses and Benefits

Mederma is positioned within the aesthetic and supportive therapeutic domains of dermatology, used primarily to improve the cosmetic outcome of healed skin injuries. The active ingredients are classified as a skin protectant, which is relevant in managing the moisture level essential to scar appearance. The product is commonly used to help address the appearance of scars, such as those resulting from surgical incisions, minor cuts, and burns, once the wound has fully closed.

Supportive Management of Scar Appearance

Its application is relevant for the long-term improvement of the appearance of the healed tissue. Mederma is commonly used to help with groups of symptoms that define a scar’s appearance, being relevant for addressing features like redness, discoloration, roughness, and tightness of the healed tissue. By supporting the scar's pliability, the product may help the tissue feel softer and smoother, which assists in supporting the goal of skin suppleness and contributes to overall aesthetic comfort. This therapeutic context also involves managing local, irritative states, as the product is applied when appropriate to help ease the dryness that contributes to discomfort.

“The supportive care aims to help the patient cope more steadily with the visual and physical changes of the healing process.”


Quick Fact: Relief for Scar Itching (Pruritus) and Dryness

This support for the skin's condition may contribute to improved comfort during periods of heightened symptoms and helps ease the overall symptom burden associated with scar maturation.

Regulatory References

  1. NIH DailyMed drug information

Eligibility and Restrictions for Use

The official regulatory profile for Mederma defines population eligibility primarily by the integrity of the skin being treated and the user's age.

Eligibility Scope

Classification Population or Condition
Use Prohibited Deep or Puncture Wounds
Animal Bites or Serious Burns
Unhealed or Open Wounds (Product is for healed skin)
Individuals with known allergy to any ingredient
Conditional Use Pregnant or Breastfeeding individuals
Age Restriction Under 2 years of age (Children's product is labeled for ages 2+)

The product is explicitly prohibited from use on any unhealed skin injuries, including deep puncture wounds, animal bites, and serious burns, as stated in the FDA Drug Facts labeling. Use is allowed only on fully closed and healed scars in the general adult population. For pediatric use, a specific formulation, Mederma for Kids, is labeled for children ages 2 and older, establishing the minimum age for routine use. For pregnant or breastfeeding individuals, the labeling advises to “ask a health professional before use,” designating this as a population requiring professional consultation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for topical products containing the active ingredients found in Mederma (such as allantoin and dimethicone) does not specify a list of contra-indicated medicines or product classes. There are no known significant pharmacokinetic interactions reported for these topical components, as they are formulated to work locally and exhibit minimal to no systemic absorption when applied to the skin.

General Interaction-Related Constraints

Regulatory labeling for products like Mederma PM (Dimethicone topical) includes procedural constraints for safe use, particularly in the context of other treatments or health conditions. The official FDA-mandated statement advises that the medicine “may interact with other drugs or health problems,” indicating a need for caution rather than a documented clinical interaction.

Therefore, patients are instructed to:

  • Inform their healthcare provider and pharmacist about all current medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins.
  • Verify safety with a healthcare professional to ensure Mederma can be used concurrently with all existing drugs and health issues.
  • Refrain from starting, stopping, or changing the dose of any other medicine without first consulting a doctor.

No specific medicinal products, substance categories, or timing-based separation rules are explicitly listed in regulatory documents as required for use with Mederma.

Mechanism of Action

How Mederma Works

Enhancing Skin Hydration and Pliability

This mechanism focuses on modulating the physical properties of the outer skin layer (stratum corneum). Active components increase the tissue's capacity for water retention and promote the gentle renewal of surface cells, which contributes to the physiological consequence of modulation of tissue pliability.


Remodeling the Extracellular Matrix Structure

The formula influences the activity of fibroblasts, the cells responsible for producing structural proteins like collagen and the surrounding matrix. By modulating these cellular signals, the mechanism supports the reorganization of disorganized fibrous material into a more regular, flatter arrangement, thereby supporting the establishment of a more regular and even dermal surface organization.


Dampening Localized Inflammatory Responses

Components of the product act as modulators that minimize the release of pro-inflammatory mediators and cytokines at the application site. This mechanism helps to suppress the local immune response and attenuate irritation signals, resulting in the physiological consequence of attenuation of localized erythema and edema.

Dosage and Administration Information

Official Administration Guidelines

Mederma is intended exclusively for topical administration, which involves applying the specific gel or cream formulations directly to the cutaneous surface. The product is indicated for use only after the skin is fully intact and healed; application must not be initiated until the wound has completely closed, the scab has fallen off, or any stitches have been removed.

Standard administration involves taking a small amount of the product and gently massaging it into the scar tissue until it is fully absorbed. The usual application frequency for the core scar management regimen is once daily. Certain formulations, such as those designated for nighttime use, are intended to align with the skin’s regenerative cycle.

Dosing recommendations for specific products are based on their active components. Formulations containing sunscreen, for instance, are to be applied liberally 15 minutes before sun exposure and reapplied at least every two hours while exposed. This long-term use pattern is essential to the regimen, corresponding to the natural duration of scar maturation.

Regarding specific populations, an advisory is given to consult a doctor before administering the product to children under six months of age. A necessary procedural constraint requires the application amount to be reduced if peeling or flaking of the treated skin is observed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Mederma

This overview describes the scope and structure of the scientific research that has examined topical Mederma (Cepalin/Onion Extract formulations), outlining what was studied and what remains uncertain, without offering any clinical advice or making claims about guaranteed results.


Evidence for Use in New Post-Surgical Scars

Research into the application of this product for new scars, such as those resulting from surgical incisions or healed injuries, primarily involves short-term randomized controlled trials (RCTs) and specialized study designs. These studies were evaluated in healthy adults shortly after their wounds had fully closed. Research explored measurement of changes in the cosmetic appearance of the scars over a defined time interval. Research described patterns in these measurements over the observed period compared to control groups in some trials. However, findings were mixed when the product was studied against other topical formulations used in scar management.

Evidence for Use in Established Scar Types (Atrophic and Elevated Scars)

The evidence available for applying this product to established, older scars—including atrophic scars and elevated scars (hypertrophic and keloids)—is limited. Research exploring these scar types involves smaller, specialized studies. For atrophic scars, the data describe patterns in cosmetic measurements, but the sample sizes were modest. For hypertrophic and keloid scars, systematic reviews examined physical dimensions like height and hardness. Here, the certainty remains low for managing these features, and findings were mixed regarding sustained physical change.

What Is Still Uncertain About Mederma's Evidence

Most published clinical research concerning this formulation was observed in contexts where the follow-up durations were limited, typically lasting only a few months. Long-term effects are not fully established. The evidence quality varies across studies, leading to low certainty when assessing the product's specific place in the evidence landscape. Furthermore, the results apply only to the populations studied, meaning the data for certain groups, such as pediatric populations (children), remain insufficient.

Key Studies & References

  1. FDA Human OTC Drug Monograph System: Dimethicone (Set ID 255e2d6b-b26a-4c28-98e3-05060b050d27)
  2. Botanicals in Dermatology: An Evidence-Based Approach to Scar Management - Review on Allium Cepa
  3. NIH DailyMed Drug Information for Mederma (Skin Protectant Formulation) (Set ID 25bc1eae-3502-4c63-bd8a-43be2dfb0d6d)

Frequently Asked Questions (FAQ)

Common questions about Mederma (FAQ)

Q: Is Mederma safe to use on older scars, or only newer ones?

Official product information suggests a specific duration of daily use based on the scar’s age. Use for established, older scars may be suggested for a longer period, such as three to six months, compared to the duration recommended for newly healed scars.


Q: Does Mederma work on acne scars?

Specific Mederma formulations, such as the Scar Cream + SPF 30 product, are regulated for use on scars resulting from acne. This is in addition to the product's intended use for scars caused by surgery, burns, or general injuries.


Q: What is the difference between Mederma and a basic skin moisturizer?

Regulatory labeling classifies Mederma as a combination over-the-counter drug, primarily categorized as a Topical Emollient and Skin Protectant. While it helps retain moisture (like a basic moisturizer), it is also formulated with the botanical extract Cepalin, and its intended purpose is the aesthetic improvement of scars.


Q: Are there different versions of Mederma, like a cream versus a gel?

The Mederma product line is available in different formulations. These include a gel (such as the Advanced Scar Gel), creams (like the PM Intensive Overnight Cream or Cream + SPF), and specialized products for use on children.


Q: How long do I usually need to use Mederma before official sources suggest reviewing results?

Product directions provide guidance on the expected duration of use. For newly healed scars, the suggested continuous daily use is often for at least eight weeks. For older or established scars, daily use may be suggested for three to six months.


Q: Is it okay to use Mederma and then put makeup or sunscreen over it?

Official product information generally indicates that Mederma can be used safely with other cosmetic products, including lotions and makeup. Product information suggests allowing the product to fully absorb and dry before applying other topical products.


Q: Can Mederma be used on any part of the body, including the face?

The product is regulated for topical application to the scar tissue. Official regulatory labeling does not contain specific restrictions on the area of the body where the product can be applied, provided the skin is intact and healed.


Q: Is Mederma considered a drug or a cosmetic product?

Mederma formulations are classified by the FDA and listed on DailyMed as a HUMAN OTC DRUG (Over-the-Counter Drug). It is generally categorized within the regulatory framework as a Topical Emollient and Skin Protectant.


Q: Can Mederma be used by pregnant women, according to regulatory sources?

Regulatory labeling for pregnant or breastfeeding individuals includes a procedural constraint stating they should “ask a health professional before use.” This indicates a requirement for professional consultation before the product is applied.

--,-

Q: Can I use Mederma if I have sensitive skin?

The official warning on product labels advises that if a localized skin reaction, such as irritation, is experienced and it worsens or persists for more than seven days, the regulatory label indicates that use should be stopped and a healthcare professional should be consulted.


Q: Does Mederma interact with any common topical antibiotics?

Official regulatory information does not specify a list of medicines or product classes that are contra-indicated for use with Mederma. There are no known significant pharmacokinetic interactions reported for the topical components, as they are formulated to work locally with minimal systemic absorption.


Q: Why is the active ingredient (onion bulb extract) used in Mederma?

The proprietary botanical component, Cepalin (Allium Cepa Bulb Extract), is included as part of the product’s Triple Action Formula. It is intended to support mechanisms such as enhancing skin hydration, promoting the reorganization of scar tissue, and dampening localized inflammatory responses.


Q: Is Mederma meant to flatten scars or just change their color?

The product’s intended benefit, as described in product information, is to improve the overall aesthetic quality of scars. This includes helping the scar become noticeably softer and smoother, which supports a more regular and flatter dermal surface organization.


Q: What are the inactive ingredients in Mederma?

The list of inactive ingredients varies depending on the specific product formulation (e.g., gel versus cream). These ingredients are explicitly detailed on the official drug facts label for each product and may include purified water, alcohol, xanthan gum, lecithin, and various preservatives.


Q: Does Mederma contain parabens or common preservatives?

Certain Mederma formulations list preservatives in the inactive ingredients section of the official drug facts label. For example, the Advanced Scar Gel formulation lists Methylparaben and Sorbic Acid as ingredients.


Q: Can I use other lotions or creams at the same time as Mederma?

Official product information indicates that Mederma can be safely used with other cosmetic products such as lotions and makeup. Product information generally suggests allowing Mederma to fully dry before applying other creams or lotions.


Q: Does Mederma cause the skin to be more sensitive to the sun?

Official labeling does not list the product as a known photosensitizing agent. However, general warnings for topical skin products advise users to always consider limiting sun exposure or using sun protection when spending time outdoors.


Q: Is it normal to feel a tingling sensation after applying the product?

Officially documented local adverse reactions at the application site include stinging and irritation. While 'tingling' is not specifically listed, it is closely related to these sensations. If any irritation is persistent or worsening, official warnings indicate that use should be stopped and a doctor should be consulted.


Q: Are there different recommended uses for Mederma on surgical scars versus injury scars?

Regulatory guidance and product directions typically differentiate the recommended duration of use based on the age of the scar (newly healed versus established/older). The directions generally do not vary based on the specific origin of the scar, such as whether it resulted from surgery or a general injury.


Q: Is there a limit to how long I can continue using Mederma?

Product directions suggest a defined treatment course designed to align with the natural duration of scar maturation. For established scars, this course is often recommended for three to six months of continuous daily use.


Q: Why do official sources sometimes mention different application times?

Differences in application frequency are based on the product’s active ingredients. Formulations containing sunscreen are mandated to be reapplied frequently while exposed to the sun, whereas the core scar management regimen is typically directed for once-daily use.


Q: Is it required to wash the treated area before each application?

Product information suggests applying the product when the skin is clean. This helps ensure optimal absorption into the scar tissue.


Q: Can Mederma be used for stretch marks?

The Mederma product line includes a specific, distinct formulation called Mederma Stretch Marks Therapy. This is a regulated product that is clinically studied and intended for use on stretch marks, separate from the primary scar management gel or cream.


Q: Is Mederma a product that must be used continuously for effectiveness?

The product directions recommend that Mederma be used daily for the duration of the defined treatment course. This continuous regimen is suggested to align with the process of scar maturation.

How should Mederma be stored and disposed of?

How to Store and Dispose of Mederma

All storage and disposal requirements for Mederma, an Over-the-Counter (OTC) topical product, are derived exclusively from official regulatory labeling.

Storage Conditions

Mederma must be stored at room temperature and requires protection from both excessive heat and direct sun. No instructions regarding storage after opening or stability periods are provided in the official labeling.

Child Safety

It is mandatory to keep this product out of reach of children. The official labeling instructs that if the product is swallowed, individuals must immediately get medical help or contact a Poison Control Center right away.

Disposal of Unused Product

Specific disposal instructions are not detailed on the product label. Unused or expired Mederma should be disposed of according to local pharmaceutical waste procedures or general non-hazardous medicine disposal guidelines issued by national health authorities, such as the FDA.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mederma found in:

A-Z Index: